Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner
Authors:
- Chih-Jen YangCYChih-Jen Yang
- Chau-Chyun SheuCSChau-Chyun Sheu
- Ming-Shyan HuangMHMing-Shyan Huang
- Herng-Chia ChiuHCHerng-Chia Chiu
- 1 November 2014
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 86 (2) , 137-143
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Lung cancer mortality in European men: Trends and predictionsLung Cancer, 2013
- The effect of metformin and thiazolidinedione use on lung cancer in diabeticsBMC Cancer, 2012
- Antidiabetes Drugs Correlate With Decreased Risk of Lung Cancer: A Population-Based Observation in TaiwanClinical Lung Cancer, 2012
- Increased Lung Cancer Risk among Patients with Pulmonary Tuberculosis: A Population Cohort StudyJournal of Thoracic Oncology, 2011
- Diabetes and CancerDiabetes Care, 2010
- Incorporation of a Genetic Factor into an Epidemiologic Model for Prediction of Individual Risk of Lung Cancer: The Liverpool Lung ProjectCancer Prevention Research, 2010
- Lung Cancer Susceptibility Model Based on Age, Family History and Genetic VariantsPLOS ONE, 2009
- Dose–response relationship between tobacco and lung cancer: new findingsEuropean Journal Of Cancer Prevention, 2003
- Lung cancer and related risk factors: an update of the literaturePublic Health, 2003
- Occupation and smoking as risk factors for lung cancer: A population‐based case‐control studyAmerican Journal of Industrial Medicine, 2003